Snakebite envenoming

JM Gutiérrez, JJ Calvete, AG Habib… - Nature reviews Disease …, 2017 - nature.com
Snakebite envenoming is a neglected tropical disease that kills> 100,000 people and
maims> 400,000 people every year. Impoverished populations living in the rural tropics are …

Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity

MN Meriggioli, DB Sanders - The Lancet Neurology, 2009 - thelancet.com
Acquired myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction
in which patients experience fluctuating skeletal muscle weakness that often affects selected …

Foodborne botulism: clinical diagnosis and medical treatment

D Lonati, A Schicchi, M Crevani, E Buscaglia… - Toxins, 2020 - mdpi.com
Botulinum neurotoxins (BoNTs) produced by Clostridia species are the most potent
identified natural toxins. Classically, the toxic neurological syndrome is characterized by an …

A systematic review of diagnostic studies in myasthenia gravis

M Benatar - Neuromuscular Disorders, 2006 - Elsevier
We performed a systematic review to identify studies that reported the accuracy of tests for
the diagnosis of myasthenia gravis. We identified 20 studies of reasonable, although …

Autoimmune pathology in myasthenia gravis disease subtypes is governed by divergent mechanisms of immunopathology

ML Fichtner, R Jiang, A Bourke, RJ Nowak… - Frontiers in …, 2020 - frontiersin.org
Myasthenia gravis (MG) is a prototypical autoantibody mediated disease. The
autoantibodies in MG target structures within the neuromuscular junction (NMJ), thus …

Update on myasthenia gravis

BR Thanvi, TCN Lo - Postgraduate medical journal, 2004 - academic.oup.com
Myasthenia gravis is an autoimmune disorder caused by autoantibodies against the
nicotinic acetylcholine receptor on the postsynaptic membrane at the neuromuscular …

The Japanese clinical guidelines 2022 for myasthenia gravis and Lambert–Eaton myasthenic syndrome

H Murai, K Utsugisawa, M Motomura… - Clinical and …, 2023 - Wiley Online Library
The revised Japanese clinical guidelines for myasthenia gravis (MG) and Lambert–Eaton
myasthenic syndrome (LEMS) were published in 2022. The notable points in these …

Management of myogenic ptosis

VA Wong, PS Beckingsale, CA Oley, TJ Sullivan - Ophthalmology, 2002 - Elsevier
OBJECTIVE: To review the genetics, clinical features, and management of patients affected
by myogenic ptosis. DESIGN: Retrospective, noncomparative interventional case series …

Pediatric myasthenia gravis

JH Peragallo - Seminars in Pediatric Neurology, 2017 - Elsevier
Myasthenia gravis is a disorder of neuromuscular transmission that leads to fatigue of
skeletal muscles and fluctuating weakness. Myasthenia that affects children can be …

Ocular myasthenia gravis: an update on diagnosis and treatment

E Fortin, DM Cestari, DH Weinberg - Current opinion in …, 2018 - journals.lww.com
OMG remains a primarily clinical diagnosis, but recent advances in laboratory testing can
improve the diagnostic accuracy and should be used in appropriate clinical settings. The …